MRK

anon10751075

I understand that "controllable" and "consistent" are like oil and water with 1dte options because of volatility and action being so quick on them. However I don't know how to explain it other than I'm sitting here at the desk, able to flip between 30 sec, 1 min and 5 min charts - see the trend real time and enter / exit the option that I want instantly. The majority of my positions I'm only in for a matter of minutes - riding 15 minute up or down trend and then existing with a 15-20% premium scalp. To me - this has been much easier to "control" my premium risk with regards to entry price than with trying to time long call entry points. I feel I was only successful on those because I was able to identify for instance AAPL and MRK 50/200 SMA cross overs and load up on favorable long calls. Hope that makes sense?

ChicagoanPizza

I've never been much of a LEAP person, but if I were going to play a LEAP, something I added big time to my long term and might sell some now lol is $MRK and maybe the healthcare sector in general. Faced some political risk, is arguably undervalued, has the chance to really bounce back. I'd maybe also look at emerging markets, maybe China? $BABA? Though there's a bunch of potential for political risk.

OnceALoser

Maybe I should build a dividend portfolio of underperforming stocks like MRK PFE TGT. With rates down, investors will be flocking to high dividend stocks.

Mindless_Sky_6654

Good few weeks to be a MRK bag holder

unwanted_hair

Wish I held my MRK, LLY, and REGN shares. Those gains would be offsetting my losses today.

Conny-Bravo

Big flows from yesterday I followed: Path 12/19 15c, MRK April 100c, and UNH March 400c. Also a ton of AAPL 11/14 277.5c came in right at the close.. Gonna be an interesting day

eoiioe

Whichever wsb user said buy puts on MRK as they deal will be scrapped for this week, hope you step on Lego all of December lol

Me-Regarded

I pick earnings lotto tickets wrong every time. MRK over LLY. It's almost comical

jeffrr

MRK beat and goes down like its a tradition. The same shit happened last earnings, i swear.The stock is scared to go higher.

Gl5778

Please be aware I do have a potential conflict of interest here because I own over 1,000 shares of NWBO. You need to know how to read research papers, how to verify sources, and most importantly any tiny thing that you can use to tear them apart. While also being able to think like an investor. The burden of proof is on those who publish and not the reader. All it takes is a 👍 or 👎 from a group of regulator’s. One you make an assload of a gains the other near certain catastrophic loss in the stock you have. These are not MRK, GSK, J&J, and LLY that can /will soak up billion dollar losses on a drug and still have 40 others in the pipeline Will maintaining profitability. Small biotechs are very vulnerable to data manipulation, fraud, and regulatory scrutiny. I mean you need approval for profit. (Or a buyout) You have Assholes who will defraud people at all costs. Then the FDA is notorious for picking on the little guy. They don’t have the big legal teams. Only invest in if you trust the data and the conclusions that other professionals completely unrelated to the study have come to. Per google there are issues with NWBO’s study. “the company made fundamental changes to the trial design, used questionable statistical methods, and demonstrated a profound lack of transparency” The changes and statistical methodology is fine if it can be verified and replicated in other trials. The lack of transparency is a huge problem with the company. It is the big thing that makes me nervous. Anyway just my thoughts on NWBOz

NOT_MartinShkreli

I’d go long on GMAB, GILD, HALO, EDIT, or TAK before MRK

First_Newspaper129

Why on MRK?

NoMorning5015

I've got ETN as my largest position, almost by accident...bought long ago and it just surged. I wish I had built a growth portfolio out of ETFs. As of right now only 1/3 of my brokerage is in ETFs and mutual funds and the rest is individual positions. Right now I am feeding SCHG monthly, and slowly building a position in MRK, which I'll likely do until it hits $100/share.

MrBlue626

MRK, trump pump. Just pass access to IVF drugs to cut prices and increase access across insurance.

IronSnatchKitty

Calla on MRK for giving 🥭 IVF babies.

salty0waldo

I don't really look for dividends since you'd expect less capital appreciation, but the dividend is certainly covered for FY2026. A yield of 7-8% is almost always a red flag though. I'm not buying at these levels for what it is worth. It really hinges on the performance of their pipeline/growth portfolio. Honestly all of pharma is in a tough place at the moment. I know a lot of people believe NVO is undervalued but I can't wrap my head around their valuation when their big product is GLP-1s with all the competition in the space. Usually whomever is first in a space isn't always the winner. If you look at BMY, its trading at a forward multiple of 6-7 which is insane; however, we are already seeing the negative effects of LOE. MRK is another that is way overvalued with a multiple of 9 when you consider their loss their main product within the next year or two.

Vegetable-Group520

Why is FEMY pumping when they named MRK as the partner in this?

Pleasant_Reason_5329

MRK is the ticker they are partnering with

Traditional-Bass-390

$MRK

Traditional-Bass-390

But MRK quick

Ancient_Climate_2831

I have been adding to THQ. A health care CEF selling at a discount with a 12% interest rate and monthly payouts. There is some return of capital in their distributions, but considering how poorly the sector has done in past year there should be more ST and LT gains in the future. Also adding opportunistically to BMY and MRK positions to include short puts and calls. Selling calls on PFE to unwind the big bag I have been holding since COVID.

BioTrends_USA

The past is the past. Everything was overhauled in 2022, and the company is now in a much stronger position. They’re currently running combination trials in collaboration with respected names like Merck (MRK), Genentech/Roche, BGF, and several other reputable research institutions. It’s definitely worth doing your own due diligence and making an informed decision.

Real_Ad_7668

People be thinking they can hurt me emotionally and I tell them I held $MRK for five years then they realize I have no soul.

Dogdowndog

I’m in VOO but also BRKB and very happy with both. I also have MAIN, PRU, MRK AND TSLA

Fancy-Lavishness9034

Merck (MRK). Took a beating these last 1-2 years, basically reset its own inflation cycle. Doesn't even matter if they can make more drugs - they have enough cash to keep buying back shares until they get their next wonder-treatment.

80delta

If XLV and SPY stay bullish, Healthcare stocks. MRK, MRNA, RXRX, CNC, SRPT all on the radar. I'll figure out which one/s based on the morning price action.

goodb1b13

Anyone doing MRK or BMY for the possible taco on pharma tariffs?

Pharmacologist72

They are undervalued but imo upside is not that awesome right now. Kind of like Pfizer. For my money, NVO and MRK are best. YMMV.

bapachonz

I sold all mine today to buy biotech stocks like MRK and PFE. complete regard move but hoping for the best 🥲

Mediocre_Froyo_3823

MRK ABBV UNH BMY. Make Health Win Again.

DamageAdventurous433

Is no one talking about MRK? I think this shit going to 110.

tachyonvelocity

Lol you guys are completely sleeping on biotech, PFE/MRK another huge gap up because tariffs are a nothingburger, but the point is biotech was literally having a big recession crash and became cheap as fck, even the servicers like TMO, WST, DHR, IQV, ICLR, BIO, TECH, AVTR all having 5% gap up days today.

SirPounces

MRK 10/3 calls printing today

sheep_classes

MRK ❤️

moorhound

#Buy all the fuckin' US pharma stocks tomorrow. LLY, JNJ, ABBV, MRK, PFE,BMY, AMGN, GILD, fucking all of em

The_Brand94

I mean if MRK keeps dropping, might be a full port yolo on leaps.

This_Refuse2365

Most pharma stocks are insanely undervalued (NVO, MRK, PFE, and LLY to name a few of the big ones). Sector rotation happens.

Maleficent_Ad_3070

So calls on MRK?

salty0waldo

I have held PFE for a while and it’s one of my worst performers. Likely should have sold during the COVID pump but I felt they would use that in rush of FCF to acquire something worth while. At this point, it’s a falling knife. I would not enter a new position. I’m holding to see a technical bounce near 28 before exiting. Their pipeline has a ton of products, but they are all weak. It’s the same as BMY. Both of these are dying pharma that will continue to have negative price action YoY for the next decade. The valuation looks cheap on a P/E standpoint but top like continues to decrease. You can only cut costs and improve efficiency for so long before it doesn’t help. The market is looking for growth, and pharma like PFE, BMY, and MRK have zero growth catalysts.

groceriesN1trip

A bunch of safe(ish) low priced, good value heath stocks ughed today. DHR ISRG MRK TMO. My assumption is they were shorted to pay for the TSLA short losses that forced the buys… just a guess

Physical-Squirrel-40

EVAX I don’t understand why EVAX doesn’t get more attention. I STRONGLY encourage folks to take a look, do your diligence, and thank me later. EVAX is an AI-based biotech pharmaceutical company focused on utilizing AI to create new immunology vaccines. They have three vaccines in various stages of trials: EVX-01 (treatment of metastatic melanoma; in phase 2 trials); EVX-02 (DNA-based vaccine to treat respected melanoma; completed phase 1 / 2A trials); EVX-03 (DNA-based vaccine for treatment of various cancers, including non-small cell lung cancer). They also have several pre-clinical stage vaccines in the works. Here is why I like it (in addition to the focus on utilizing AI which I think will be the future of biopharma): MERCK! Merck & Co (NYSE: MRK; one of the largest healthcare and pharmaceutical companies in the world) is their strategic partner and investor. - Merck is an investor through its venture investment vehicle (MSD Global Health Innovation Fund). They purchases shares in two private placements (December 2023 and January 2025). - Merck paid EVAX $3.2 million in September 2024 for options to license two vaccine candidates EVX-B2 and EVX-B3. If Merck chooses to exercise the option, they must pay EVAX another $10 million this year (2025), plus EVAX is entitled to development, regulatory, and sales Milestones totaling up to $592 million PER PRODUCT. Plus, EVAX would receive royalties on sales (in addition to the payments mentioned). EVAX is currently trading at a market cap of $19 million. This is essentially nothing relative to the monies they stand to make from the Merck relationship, not to mention their other vaccine candidates. The stock has been beaten down as most biopharma companies are in between PR announcements and prior to announcements of approvals. It is currently trading around $3.00 per share, down from its 52-week high of $17.20, and up from its 52-week low of $1.20. Disclosure: I am a shareholder. My average basis is $1.78. I initially bought shares in early February 2025 after reading about the relationship with Merck and the fact that Merck had just expressed continued believe via their purchase of more shares in late January 2025). My initial purchases were in the high $3’s and up to $4.09 per share. I then continued to buy throughout the market dip this spring. I hold because I believe this will scream upward on any good news announcements and/or via Merck making the next $10 million option payment. I am not a bag holder. I could sell today and make a 67% profit (nearly $50k of profit).

pacificbeachRay

Over 15 years for me: AAPL, KO, MRK, and CVX all in DRPs. Not that I’d make those same plays today. ETFs for long term. Playing with RBLX, RIVN, NVDA, and TSM

Strict_Push4722

Depends how much you're starting with. I buy large cap dips. This year I bought TSLA and UNH near the bottom. Patience was key, but a lot of it was luck. I got 25% return on my TSLA before selling and recently sold UNH for a 20% return. Each time I dumped in about $200k. Taxes will suck, but I'm up almost $100k pre tax. I bought MRK yesterday morning. Put in $150k. We'll see in the next couple months if I'm 3 for 3 this year! Absolutely never do this with small caps or companies that have excessive debt. Losses are one thing, but a company bankruptcy could set you back a long time.

Difficult_Physics704

Other NON-penny stock long-term growth stocks include: NVO, UNH, UPS, CART, MRK, AMZN, RIGL, BAYRY, SO, PEP

jarMburger

$NVO is worthwhile, so as $MRK. Healthcare sector is undervalued as whole lately. But I think $LULU and $STZ is facing some demographic taste shift and it's going down more, especially for $LULU.

superbilliam

Thoughts on FMC? I like MRK and NOVO. I'm worried that LULU is sacrificing quality for margin growth, which consumers will notice and then switch away to a competitor. Maybe their expansion plans will overcome this issue, but it seems like the first hole in their boat. Hopefully, they repair that before it causes bigger issues.

chancepack

MRK killing me right now

Thin_Cat8817

Yesterday I said i would eat shrooms, go into the desert, and come back with a ticker I'm back, and 3 letters came to me "M M R". I looked this up and did not find a ticker, but instead "Measles Mumps and Rubella" I looked up who makes the vaccine for this virus, and apparently it's Merck (MRK) and some british company called GSK. Do what you will with this information Thank you for your attention to this matter, regards

Aretardinvestor

Yes, Keytruda is coming off patent BUT the pipeline is VERY strong. If I recall correctly, they're already working on Keytruda + several adjuvants that would essentially give them another 20y patent ( it's been a while since I reviewed MRK) I highly doubt a blockbuster like Keytruda will be abandoned by MRK MRK is my favorite out of big pharma. REGN, from my analysis has a much weaker pipeline and IMO is going to have trouble replacing EYLEA. AND at current prices both MRK and REGN are good buys, probably the best value out of big pharma.

Aretardinvestor

MRK is the best out of the 3, I specialize in biotech investing and it's currently my favorite pick out of the big pharma, followed closely by REGN and NVO. The other one I have no opinion on 🤷🏻

rickochetl

Statistics major here. Nice chart, but my 2c is that it doesn't really say a lot about 2/3 of your picks. Theoretically, you'd be looking for outliers. An outlier would typically be something that's way outside the cluster in some way. CMCSA visually appears to be an outlier in this sense, but only because it has a low PE. MRK and REGN appear to be solidly within the cluster, and not particular outliers.

RobertFrost_

MRK is in the doldrums due to 3 reasons. One, they have the Keytruda patent cliff coming in 2028. Keytruda comprises of over 60% of their revenue, and while they do have a big release pipeline there’s no guarantee that those drugs will make up for the loss of revenue from Keytruda. Two, they just announced a “multi year optimization” wherein they will be laying off close to 6000 people. That is not the sign of a well oiled enterprise where things are going well. Three, their sales of Gardasil in China just went to 0 over the last 2-3 quarters. That’s also a significant revenue loss that was unexpected. Not saying your DD isn’t solid, just trying to share the market sentiment and details behind it.

oldwhitch

MRK and NVO pumping

policygeek80

Time to move away from IA stocks and invest in great robust old business stocks such as NESN, PFE and MRK!

policygeek80

Time to move away from IA stocks and invest in great robust old business stocks such as NESN, PFE and MRK!

Plus_Seesaw2023

That's incredible! We need more days like this! While tech is being decimated... other sectors are attracting all the money! Berkshire, AZN, MRK, ... TJX, DOW, UL, ABBV, ...

oldwhitch

MRK safe haven 🙏🏼

Mindless_Sky_6654

MRK!

Loose-Landscape2686

Agreed. Data was not 100% blowout so its a sell the news event. Fact is, VKTX remains the only direct competitor to LLY because the molecule is nearly identical with the same MOA. LLY will be announcing their oral Tirzepetide product soon I bet, this will further validate VKTX as a solid play. Will it be the best product on the market? maybe, maybe not. Will it be top 3? yes with LLY and NVO. Is it better than PFE, AMGN, MRK, Roche, etc? Yep. If those companies want to compete its the right company to partner with. Lastly, NVO's cost to mfg is huge compared to Tirzepetide, I imagine VKTX will have similar costs to LLY when all is said an done. meaning as price erodes VKTX still has an opportunity to capture a good portion of market share from NVO.

justsquanchythings

20k on MRK 88’s this Friday what’s that about 👀

oldwhitch

Anyone trade pharmaceuticals? I like the setups for MRK and NVO

Xzlk

They file 13F’s. It’s not really meme stocks. But UNH calls, LLY calls, MRK calls, VRTX calls, and HD calls were added.

Mindless_Sky_6654

MRK (I one a lot of it)

Secure_Plantain_829

Oral data due imminently, fireworks to come, could see plus or minus $25. My bet is plus given the overwhelming positive data released in both SQ and oral. Remember it’s the same compound. Just a matter of time before PFE, MRK or ABBV takes them out imo.

Mindless_Sky_6654

MRK is gonna pop off in the next few months.

zangor

There have been some good arguments for MRK. Keytruda is the best selling medicine of the last year. Even tho there is patent expiration, similar to NVO the company with be worth more eventually. Plus 6% dividend. But I also understand there are better things to buy.

tashtrader

First off — respect for getting back in the ring after the ARM lesson. MRK condor actually looks reasonable here: tight range, post-earnings quiet, and IV still decent. Just make sure you’re sizing for boredom — condors are the "watch paint dry" trade until they’re not. Rooting for a peaceful $80.50 week.

cforb92

JNJ, KO, MRK, PG. other than that I’m in a sea of red

GoodLittleDancer

I think big pharma and biologics companies will benefit most if Prez's tariffs are deemed unconstitutional by the Appeals court or supreme court. Loading the boat with LLY, DHR, TMO, MRK.

OilBull

Opened longs on: $AVGO $GOOG $VGT $TQQQ $IBM $AMD $NVO $REGN $MRK

E39_CBX

I only made 40% on MRK calls today but I should’ve held and I would’ve made 300% fuck this

ThinkingOfTheOldDays

nice reversal on MRK

yungluke_

$MRK rebound

E39_CBX

!BANBET MRK $80 1w

DontMessWithYohan

Fubo calls, MRK puts

GamblingMikkee

Every real company that reports gets hammered. RCL SPOT MRK UNH PYPL etc How are we green again lmao

CUbuffGuy

Every ER I see is dog shit, how is spy green. UNH, UPS, PG, MRK, SPOT There were 2 good ones… somehow those are the only ones that matter.

W_Malinowski

ups missed by 1 cent and is a barometer for economic activity, UNH massive miss, Spotify, Whirlpool last night, MRK. seems like majority of companies are missing estimates or drilling on guidance rn

GrouchyFroot

SPOT, UPS, MRK, RCL, all down lol, bulls better pray for PYPL and BA and SOFI to moon

Unlikely-Wall-1513

Full port $MRK calls now, 2minutes left

Ok-Run-8643

This become like pump and dump a different shit meme stock a day. We can do the same but with something good instead . Like $MRK is really undervalued right now, real upside and worst case escenario , the stock paid 4% dividend. So if you are going to be a bag holder at least you are getting a good interest rate.

Apprehensive_Two1528

stay away MRK. my biggest $ loser and #2 percentage loser out of my beat s&p materially portfolio. Has no signs of coming back. even worse than pfe Honestly, i will

Negative_Song_6362

I like this. I am going Long MRK 8/15 80C. The IV is so low these pharma stocks only need to rally 3% to double your money.

RichardAdams1973

STZ (specifically Modelo) is the best selling beer in US. I bought within the last month because of their valuations, technicals, and the fact that I as a young person really enjoy it and so do my friends. Young people are still drinking! I also have BMY and MRK as an aside.

dvdmovie1

"Thermo Fisher Scientific TMO Danaher DHR" Good companies but you had oversupply post covid, among other issues. DHR's earnings actually weren't bad but were overshadowed a bit by disappointing earnings from Sartorius this am. TMO is tomorrow I think? If you expect these to have some sort of major turnaround tomorrow, you're going to be disappointed, but I think both could do okay over the next few years. "Constellation Brands STZ Brown-Forman BF.B" People are drinking less + alcohol names are a prime example of "if it's not working, I don't want anything to do with it." At some point that's baked in, but looking forward what changes the fact that younger people seem less interested in drinking? Alco I mean also, Constellation has shit capital allocation - they lost close to a billion on Ballast Point and their investment in Canopy has lost them a few billion. "Campbell’s CPB" Have at least made a couple of decent purchases (Rao.) Maybe break it up into soups and everything else? "Merck MRK" I'm thankful for the company they bought recently that I owned, but for Merck it's part of a process of trying to refill the gap left when Ketruda's patent expires. https://www.forbes.com/sites/greatspeculations/2025/07/11/mercks-verona-acquisition-plugging-a-4b-hole-in-a-20b-gap/ "GSK GSK Bristol-Myers Squibb BMY" Meh.

Difficult_Eye1412

this company’s book value is @$700 million, its cap right now is only a little over a billion. its survived 4 years of worst mortgage interest rate home sale squeeze in 20 years. i Am taking a gamble on what they can do over next 2 years. At a $1.6 a share, if it goes back to half its peak that comes in at $15/share. If it tanks to .50 then great it can go on the pile with MRK and my other “safe” health sector stocks that halved. average investors don’t get access to the juicy pre-IPO returns, this is as close as we can get (as of now) and frankly, probably better odds since this is an actual company doing business.

Fancy-Lavishness9034

MP Materials (MP), Cameco (CCJ), Loar Holdings (LOAR), Chevron (CVX), Merck (MRK)

Any-Inspection-3325

SIGH i have been saying since premarket…why choose to turn a deaf ear? good news is we will stop the dump soon FOR TODAY, ur only chance to cut losses. we will continue to dump over the few weeks. in the meantime the index will go up a little as we readjust portfolio if u prefer to hold stocks buy NKE PG CPB KHC CAG JNJ MRK XHB ABBV BRKB UNH

Any-Inspection-3325

congrats to all with their puts, would not recommend to buy 0dte, but 14/30 puts are guaranteed profit. those not into options can buy XHB CPB KHC MRK CAG PG BRKB NKE or short any tech and ipo, rotation is coming soon

xband23

Market seems a bit frothy, but I won’t stop DCA’ing SPY or similar. Like most people here, I think GOOGL is a great way to play AI with diversification across a few other areas. Think the negative press regarding Google search vs AI is way overblown. It’s beaten down a bit, but I love MRK under $85. Do some research on their upcoming patent expirations, but I think it’s priced in, has a promising pipeline, and good upside potential with a dividend and defensiveness to balance against a heavy-tech portfolio.

EscortSportage

It everything is at an all time high though, MRK is around a 5 year low.

SmokyToast0

MRK

Apprehensive_Two1528

MRK PFE have some movements recently but they failed to go past the $85 and $27 resistance I have hold them since 2022 and 2023. my top losers, by percentage and $ amount LDOs recently went above its resistance of $162.. It’s a stable growth. I’d own some ldos

568Byourself

Positions going into this week I have a SPY lotto put for Monday (619, and I already know that will be dead with the news that just dropped) VISA call spreads that expire after earnings TSLA put spread for this Friday APLD calls and call spreads MRK calls that expire after earnings HIMS put spread VIX call spread

dig000

MRK, PLMR, ODC, V, SCI I think MRK is due for a turnaround and the worries about patent expiry are priced in, which is attractive to me. PLMR is a bit speculative, but they’ve done stellar. ODC is a small company that my friend works at, and they just keep performing. V and MA are both good choices, but I like V ever so slightly more. SCI because people will keep dying.

Arthurooo

Need a MRK rally

Arthurooo

HOOD and MRK so disappointing :/

dvdmovie1

IMO it's rotation out of what's been working to what's not (retail, homebuilders, some consumer staples - MDLZ up 2% and health care that hasn't been working (REGN, MRK, ABBV, JNJ, etc.)

throwawaydonaldinho

Looks like they partnered with Moderna for an mRNA variant. May extend patent or jus cause docs to prescribe MRK over others since trials indicate massive improvement as ive read.

throwawaydonaldinho

Looks like they partnered with Moderna for an mRNA variant. May extend patent or jus cause docs to prescribe MRK over others since trials indicate massive improvement as ive read.